Summary
This systematic review synthesised 168 human studies published between 2010 and August 2026 to evaluate plant-based diets (PBDs) as a therapeutic strategy for obesity management. The evidence supports beneficial effects of high-quality PBDs on spontaneous energy intake, insulin sensitivity, lipid metabolism, and systemic inflammation, with mechanisms including lower dietary energy density, improved lipid partitioning, increased postprandial energy expenditure, and altered gut microbial metabolism. While clinical trials demonstrate that PBDs can support weight loss, the review identifies gaps in direct human evidence for effects on central appetite regulation, brown/beige adipose tissue activation, and weight-independent molecular pathways.
Regional applicability
The findings are based on global human studies and are applicable to United Kingdom clinical and public health practice for obesity management and cardiometabolic risk reduction. However, applicability may depend on food availability, cultural dietary preferences, and the degree to which high-quality, minimally processed plant foods are accessible within UK populations.
Key measures
Body weight and adiposity, insulin sensitivity, visceral and ectopic lipid accumulation, circulating lipid profiles, energy intake, postprandial energy expenditure, oxidative and inflammatory markers, gut microbiota composition and enteroendocrine signalling, epigenetic changes.
Outcomes reported
The review synthesized evidence on weight-loss efficacy of plant-based diets and mechanisms linking them to obesity and adiposity-related outcomes, including effects on energy intake, insulin sensitivity, lipid profiles, inflammation, and gut microbial signalling.
Topic tags
Dig deeper with Pulse AI.
Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.